0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urology Drugs Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-6T8081
Home | Market Reports | Health | Pharmacy
Global Urology Drugs Market Insights and Forecast to 2028

Global Urology Drugs Market Insights and Forecast to 2028

Code: QYRE-Auto-6T8081
Report
January 2022
72 Pages
QYResearch
Region: China, Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Urology Drugs Market

Due to the COVID-19 pandemic, the global Urology Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Α (alpha) Blockers accounting for % of the Urology Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.
China Urology Drugs market size is valued at US$ million in 2021, while the US and Europe Urology Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Urology Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Urology Drugs include Astellas, Endo, GP Pharm and Tolmar, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Urology Drugs Scope and Segment
Urology Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Urology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Α (alpha) Blockers
5 α-reductase Inhibitors

Segment by Application

Hospital
Clinic
Others

BY COMPANY

Astellas
Endo
GP Pharm
Tolmar

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Urology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Urology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Α (alpha) Blockers
1.2.3 5 α-reductase Inhibitors
1.3 Market by Application
1.3.1 Global Urology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urology Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Urology Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Urology Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Urology Drugs Sales by Region
2.4.1 Global Urology Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Urology Drugs by Region (2023-2028)
2.5 Global Urology Drugs Revenue by Region
2.5.1 Global Urology Drugs Revenue by Region (2017-2022)
2.5.2 Global Urology Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Urology Drugs Sales by Manufacturers
3.1.1 Global Top Urology Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Urology Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urology Drugs in 2021
3.2 Global Urology Drugs Revenue by Manufacturers
3.2.1 Global Urology Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Urology Drugs Revenue in 2021
3.3 Global Urology Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Urology Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urology Drugs Sales by Type
4.1.1 Global Urology Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Urology Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Urology Drugs Sales Market Share by Type (2017-2028)
4.2 Global Urology Drugs Revenue by Type
4.2.1 Global Urology Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Urology Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Urology Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Urology Drugs Price by Type
4.3.1 Global Urology Drugs Price by Type (2017-2022)
4.3.2 Global Urology Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Urology Drugs Sales by Application
5.1.1 Global Urology Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Urology Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Urology Drugs Sales Market Share by Application (2017-2028)
5.2 Global Urology Drugs Revenue by Application
5.2.1 Global Urology Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Urology Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Urology Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Urology Drugs Price by Application
5.3.1 Global Urology Drugs Price by Application (2017-2022)
5.3.2 Global Urology Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Urology Drugs Market Size by Type
6.1.1 North America Urology Drugs Sales by Type (2017-2028)
6.1.2 North America Urology Drugs Revenue by Type (2017-2028)
6.2 North America Urology Drugs Market Size by Application
6.2.1 North America Urology Drugs Sales by Application (2017-2028)
6.2.2 North America Urology Drugs Revenue by Application (2017-2028)
6.3 North America Urology Drugs Market Size by Country
6.3.1 North America Urology Drugs Sales by Country (2017-2028)
6.3.2 North America Urology Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Urology Drugs Market Size by Type
7.1.1 Europe Urology Drugs Sales by Type (2017-2028)
7.1.2 Europe Urology Drugs Revenue by Type (2017-2028)
7.2 Europe Urology Drugs Market Size by Application
7.2.1 Europe Urology Drugs Sales by Application (2017-2028)
7.2.2 Europe Urology Drugs Revenue by Application (2017-2028)
7.3 Europe Urology Drugs Market Size by Country
7.3.1 Europe Urology Drugs Sales by Country (2017-2028)
7.3.2 Europe Urology Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Urology Drugs Market Size by Type
8.1.1 Asia Pacific Urology Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Urology Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Urology Drugs Market Size by Application
8.2.1 Asia Pacific Urology Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Urology Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Urology Drugs Market Size by Region
8.3.1 Asia Pacific Urology Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Urology Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Urology Drugs Market Size by Type
9.1.1 Latin America Urology Drugs Sales by Type (2017-2028)
9.1.2 Latin America Urology Drugs Revenue by Type (2017-2028)
9.2 Latin America Urology Drugs Market Size by Application
9.2.1 Latin America Urology Drugs Sales by Application (2017-2028)
9.2.2 Latin America Urology Drugs Revenue by Application (2017-2028)
9.3 Latin America Urology Drugs Market Size by Country
9.3.1 Latin America Urology Drugs Sales by Country (2017-2028)
9.3.2 Latin America Urology Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Urology Drugs Market Size by Type
10.1.1 Middle East and Africa Urology Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Urology Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Urology Drugs Market Size by Application
10.2.1 Middle East and Africa Urology Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Urology Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Urology Drugs Market Size by Country
10.3.1 Middle East and Africa Urology Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Urology Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astellas
11.1.1 Astellas Corporation Information
11.1.2 Astellas Overview
11.1.3 Astellas Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astellas Recent Developments
11.2 Endo
11.2.1 Endo Corporation Information
11.2.2 Endo Overview
11.2.3 Endo Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Endo Recent Developments
11.3 GP Pharm
11.3.1 GP Pharm Corporation Information
11.3.2 GP Pharm Overview
11.3.3 GP Pharm Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GP Pharm Recent Developments
11.4 Tolmar
11.4.1 Tolmar Corporation Information
11.4.2 Tolmar Overview
11.4.3 Tolmar Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tolmar Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urology Drugs Industry Chain Analysis
12.2 Urology Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urology Drugs Production Mode & Process
12.4 Urology Drugs Sales and Marketing
12.4.1 Urology Drugs Sales Channels
12.4.2 Urology Drugs Distributors
12.5 Urology Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Urology Drugs Industry Trends
13.2 Urology Drugs Market Drivers
13.3 Urology Drugs Market Challenges
13.4 Urology Drugs Market Restraints
14 Key Findings in The Global Urology Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Urology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Α (alpha) Blockers
    Table 3. Major Manufacturers of 5 α-reductase Inhibitors
    Table 4. Global Urology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Urology Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Urology Drugs Sales by Region (2017-2022) & (MT)
    Table 7. Global Urology Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Urology Drugs Sales by Region (2023-2028) & (MT)
    Table 9. Global Urology Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Urology Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Urology Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Urology Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Urology Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Urology Drugs Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Urology Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Urology Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Urology Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Urology Drugs Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 19. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2021)
    Table 21. Urology Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Urology Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Urology Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 26. Global Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 27. Global Urology Drugs Sales Share by Type (2017-2022)
    Table 28. Global Urology Drugs Sales Share by Type (2023-2028)
    Table 29. Global Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Urology Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Urology Drugs Revenue Share by Type (2023-2028)
    Table 33. Urology Drugs Price by Type (2017-2022) & (USD/Kg)
    Table 34. Global Urology Drugs Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 35. Global Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 36. Global Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 37. Global Urology Drugs Sales Share by Application (2017-2022)
    Table 38. Global Urology Drugs Sales Share by Application (2023-2028)
    Table 39. Global Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Urology Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Urology Drugs Revenue Share by Application (2023-2028)
    Table 43. Urology Drugs Price by Application (2017-2022) & (USD/Kg)
    Table 44. Global Urology Drugs Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 45. North America Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 46. North America Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 47. North America Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 50. North America Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 51. North America Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Urology Drugs Sales by Country (2017-2022) & (MT)
    Table 54. North America Urology Drugs Sales by Country (2023-2028) & (MT)
    Table 55. North America Urology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Urology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 58. Europe Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 59. Europe Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 62. Europe Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 63. Europe Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Urology Drugs Sales by Country (2017-2022) & (MT)
    Table 66. Europe Urology Drugs Sales by Country (2023-2028) & (MT)
    Table 67. Europe Urology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Urology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Urology Drugs Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Urology Drugs Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Urology Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Urology Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Urology Drugs Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Urology Drugs Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Urology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Urology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Urology Drugs Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Urology Drugs Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Urology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Urology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Urology Drugs Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Urology Drugs Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Urology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Urology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Urology Drugs Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Urology Drugs Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Urology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Urology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Astellas Corporation Information
    Table 106. Astellas Description and Major Businesses
    Table 107. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 108. Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Astellas Recent Developments
    Table 110. Endo Corporation Information
    Table 111. Endo Description and Major Businesses
    Table 112. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Endo Recent Developments
    Table 115. GP Pharm Corporation Information
    Table 116. GP Pharm Description and Major Businesses
    Table 117. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. GP Pharm Recent Developments
    Table 120. Tolmar Corporation Information
    Table 121. Tolmar Description and Major Businesses
    Table 122. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Tolmar Recent Developments
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Urology Drugs Distributors List
    Table 128. Urology Drugs Customers List
    Table 129. Urology Drugs Market Trends
    Table 130. Urology Drugs Market Drivers
    Table 131. Urology Drugs Market Challenges
    Table 132. Urology Drugs Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Urology Drugs Product Picture
    Figure 3. Global Urology Drugs Market Share by Type in 2021 & 2028
    Figure 3. Α (alpha) Blockers Product Picture
    Figure 4. 5 α-reductase Inhibitors Product Picture
    Figure 5. Global Urology Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Others
    Figure 9. Urology Drugs Report Years Considered
    Figure 10. Global Urology Drugs Sales 2017-2028 (MT)
    Figure 11. Global Urology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Urology Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Urology Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Urology Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Urology Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Urology Drugs Sales YoY (2017-2028) & (MT)
    Figure 17. North America Urology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Urology Drugs Sales YoY (2017-2028) & (MT)
    Figure 19. Europe Urology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Urology Drugs Sales YoY (2017-2028) & (MT)
    Figure 21. Asia-Pacific Urology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Urology Drugs Sales YoY (2017-2028) & (MT)
    Figure 23. Latin America Urology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Urology Drugs Sales YoY (2017-2028) & (MT)
    Figure 25. Middle East & Africa Urology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Urology Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Urology Drugs in the World: Market Share by Urology Drugs Revenue in 2021
    Figure 28. Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Urology Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Urology Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Urology Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Urology Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Urology Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Urology Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Urology Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Urology Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Urology Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Urology Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Urology Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Urology Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Urology Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Urology Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Urology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Urology Drugs Value Chain
    Figure 87. Urology Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Nebivolol Hydrochloride Market Insights Forecast to 2028
Global Nebivolol Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12T7632
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights Forecast to 2028
Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-0T7466
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nefopam Hydrochloride Market Insights Forecast to 2028
Global Nefopam Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36U7490
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Naratriptan Hydrochloride Market Insights Forecast to 2028
Global Naratriptan Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-14C7602
Fri May 13 00:00:00 UTC 2022

Add to Cart